Crossref Citations
This article has been cited by the following publications. This list is generated based on data provided by
Crossref.
Coghill, David
and
Seth, Sarah
2006.
Osmotic, controlled-release methylphenidate for the treatment of ADHD.
Expert Opinion on Pharmacotherapy,
Vol. 7,
Issue. 15,
p.
2119.
Fallu, Angelo
Richard, Caroline
Prinzo, Rosanna
and
Binder, Carin
2006.
Does OROS-methylphenidate improve core symptoms and deficits in executive function? Results of an open-label trial in adults with attention deficit hyperactivity disorder.
Current Medical Research and Opinion,
Vol. 22,
Issue. 12,
p.
2557.
Rostain, Anthony L.
2008.
Attention-Deficit/Hyperactivity Disorder in Adults: Evidence-Based Recommendations for Management.
Postgraduate Medicine,
Vol. 120,
Issue. 3,
p.
27.
Wilens, Timothy E.
2008.
Pharmacotherapy of ADHD in Adults.
CNS Spectrums,
Vol. 13,
Issue. S8,
p.
11.
Hammerness, Paul
Surman, Craig
and
Miller, Katherine
2008.
Update on adult attention-deficit/hyperactivity disorder.
Current Neurology and Neuroscience Reports,
Vol. 8,
Issue. 6,
p.
484.
Adler, Lenard A.
Zimmerman, Brenda
Starr, H. Lynn
Silber, Steve
Palumbo, Joseph
Orman, Camille
and
Spencer, Thomas
2009.
Efficacy and Safety of OROS Methylphenidate in Adults With Attention-Deficit/Hyperactivity Disorder.
Journal of Clinical Psychopharmacology,
Vol. 29,
Issue. 3,
p.
239.
Knouse, Laura E.
and
Safren, Steven A.
2009.
Handbook of Clinical Rating Scales and Assessment in Psychiatry and Mental Health.
p.
195.
Surman, Craig
Hammerness, Paul
and
Miller, Katherine
2009.
A 2009 update on adult ADHD.
Current Attention Disorders Reports,
Vol. 1,
Issue. 3,
p.
131.
Ramos-Quiroga, J Antoni
Corominas, Margarida
Castells, Xavier
Bosch, Rosa
and
Casas, Miguel
2009.
OROS methylphenidate for the treatment of adults with attention-deficit/hyperactivity disorder.
Expert Review of Neurotherapeutics,
Vol. 9,
Issue. 8,
p.
1121.
Sopko, Michael A.
Caberwal, Harjeet
and
Chavez, Benjamin
2010.
The Safety and Efficacy of Methylphenidate and Dexmethylphenidate in Adults with Attention Deficit/Hyperactivity Disorder.
Journal of Central Nervous System Disease,
Vol. 2,
Issue. ,
p.
JCNSD.S4178.
Spencer, Thomas J.
Adler, Lenard A.
Meihua Qiao
Saylor, Keith E.
Brown, Thomas E.
Holdnack, James A.
Schuh, Kory J.
Trzepacz, Paula T.
and
Kelsey, Douglas K.
2010.
Validation of the Adult ADHD Investigator Symptom Rating Scale (AISRS).
Journal of Attention Disorders,
Vol. 14,
Issue. 1,
p.
57.
Adler, Lenard A.
Shaw, David M.
Spencer, Thomas J.
Newcorn, Jeffrey H.
Sitt, David J.
Morrill, Melinda
Davidow, Jennifer V.
Glatt, Stephen J.
and
Faraone, Stephen V.
2011.
Reliability and validity of the Time-Sensitive ADHD Symptom Scale in adults.
Comprehensive Psychiatry,
Vol. 52,
Issue. 6,
p.
769.
Buitelaar, Jan K.
Kooij, J.J. Sandra
Ramos-Quiroga, J. Antoni
Dejonckheere, Joachim
Casas, Miguel
van Oene, Joop C.
Schäuble, Barbara
and
Trott, Goetz-Erik
2011.
Predictors of treatment outcome in adults with ADHD treated with OROS® methylphenidate.
Progress in Neuro-Psychopharmacology and Biological Psychiatry,
Vol. 35,
Issue. 2,
p.
554.
Adler, Lenard A.
Orman, Camille
Starr, H. Lynn
Silber, Steve
Palumbo, Joseph
Cooper, Kimberly
Berwaerts, Joris
and
Harrison, Diane D.
2011.
Long-Term Safety of OROS Methylphenidate in Adults With Attention-Deficit/Hyperactivity Disorder.
Journal of Clinical Psychopharmacology,
Vol. 31,
Issue. 1,
p.
108.
Matte, Breno
Rohde, Luis Augusto
and
Grevet, Eugenio Horácio
2012.
ADHD in adults: a concept in evolution.
ADHD Attention Deficit and Hyperactivity Disorders,
Vol. 4,
Issue. 2,
p.
53.
Epstein, Tamir
Patsopoulos, Nikolaos A
Weiser, Mark
and
Epstein, Tamir
2014.
Cochrane Database of Systematic Reviews.
Adler, Lenard A.
Shaw, David M.
and
Alperin, Samuel
2014.
Attention-Deficit Hyperactivity Disorder in Adults and Children.
p.
224.
Katzman, Martin A.
and
Sternat, Tia
2014.
A Review of OROS Methylphenidate (Concerta®) in the Treatment of Attention-Deficit/Hyperactivity Disorder.
CNS Drugs,
Vol. 28,
Issue. 11,
p.
1005.
Lin, Yu-Ju
Lo, Kuan-Wu
Yang, Li-Kuang
and
Gau, Susan Shur-Fen
2015.
Validation of DSM-5 age-of-onset criterion of attention deficit/hyperactivity disorder (ADHD) in adults: Comparison of life quality, functional impairment, and family function.
Research in Developmental Disabilities,
Vol. 47,
Issue. ,
p.
48.
Epstein, Tamir
Patsopoulos, Nikolaos A
and
Weiser, Mark
2016.
Immediate-release methylphenidate for attention deficit hyperactivity disorder (ADHD) in adults.
Cochrane Database of Systematic Reviews,